Parallax Health Sciences, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by BUCCI CALLI, was filed 04 Mar 2020.
Parallax Health Sciences, Inc.: what insiders have been doing
Parallax Health Sciences, Inc. belongs to the Technology sector. Filings by its managers are published through SEC (Form 4). Nothing new has been filed by managers of Parallax Health Sciences, Inc. in twelve months, the latest record being from 17 March 2022.
Looking back to 2014, when coverage begins, insiders filed 10 purchases and no sales.
For comparison within the same sector, see the insider buying recorded at Basler Aktiengesellschaft and Lime Technologies AB (publ). Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2019FY ended December 2019 · cache
- 13,491,053 shares@ US$0.0554.5% of flowCOMMON STOCKSEC:0001388410-22-000004:1
- 7,050,773 shares@ US$0.08100.0% of flowCOMMON STOCKSEC:0001388410-22-000004:0
- 1,000,000 shares@ US$0.05100.0% of flowCOMMON STOCK (RESTRICTED)SEC:0001388410-20-000023:0
- 800,000 shares@ US$0.05100.0% of flowCOMMON STOCK (RESTRICTED)SEC:0001388410-20-000026:0
- 1,000,000 shares@ US$0.0539.3% of flowCOMMON STOCK (RESTRICTED)SEC:0001388410-20-000022:0
- 2,000,000 shares@ US$0.0549.0% of flowCOMMON STOCK (RESTRICTED)SEC:0001388410-20-000021:0
- 1,351,181 shares@ US$0.0010.7% of flowCOMMON STOCK (RESTRICTED)SEC:0001388410-20-000021:1
- 2,000,000 shares@ US$0.0548.7% of flowCOMMON STOCK (RESTRICTED)SEC:0001388410-20-000019:0Canonical exit: 30 Mar 2020 (T+90)
- 2,000,000 shares@ US$0.0549.3% of flowCOMMON STOCK (RESTRICTED)SEC:0001388410-20-000020:0Canonical exit: 30 Mar 2020 (T+90)
- 1,600,000 shares@ US$0.062550.3% of flowCOMMON STOCK (RESTRICTED)SEC:0001388410-19-000154:0Canonical exit: 29 Dec 2019 (T+90)
- 2,375,000 shares@ US$0.0011.1% of flowCOMMON STOCK (RESTRICTED)SEC:0001388410-19-000152:0
- 1,600,000 shares@ US$0.062550.1% of flowCOMMON STOCK (RESTRICTED)SEC:0001388410-19-000152:1Canonical exit: 29 Dec 2019 (T+90)
- 1,200,000 shares@ US$0.062560.7% of flowCOMMON STOCK (RESTRICTED)SEC:0001388410-19-000155:0Canonical exit: 29 Dec 2019 (T+90)
- 1,600,000 shares@ US$0.062550.7% of flowCOMMON STOCK (RESTRICTED)SEC:0001388410-19-000153:0Canonical exit: 29 Dec 2019 (T+90)
- 5,000,000 shares@ US$0.0012.2% of flowCOMMON STOCKSEC:0001388410-18-000009:0Canonical exit: 4 Jul 2018 (T+90)
- 500,000 shares@ US$0.0010.4% of flowCOMMON STOCK (RESTRICTED)SEC:0001388410-18-000007:0Canonical exit: 4 Jul 2018 (T+90)
- 2,500,000 shares@ US$0.0011.1% of flowCOMMON STOCK (RESTRICTED)SEC:0001388410-18-000005:0Canonical exit: 5 Jul 2018 (T+90)
- 500,000 shares@ US$0.0010.9% of flowCOMMON STOCK (RESTRICTED)SEC:0001388410-18-000006:0Canonical exit: 4 Jul 2018 (T+90)
- 36,462,819 sharesCOMMON STOCKSEC:0001388410-14-000003:0Canonical exit: 7 Apr 2014 (T+90)
- 36,462,819 shares0COMMON STOCKSEC:0001388410-14-000003:1
20 of 20 declarations
About Parallax Health Sciences, Inc.
Parallax Health Sciences, Inc. is a technology company focused on developing innovative health solutions. It is listed on the XNAS market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
